Cited by 65Treatment of Major DepressionTryptophan and brain disordersDiabetes Treatment and Management

Glucose Metabolism and Antidepressant Medication

M. Hennings, Johannes, Schaaf, Ludwig, Fulda, Stephany·2012·Current Pharmaceutical Design

Abstract

Impaired glucose tolerance is observed in depressed patients, and patients suffering from depression have an increased risk to develop diabetes mellitus. In depressed and diabetic patients, studies have shown both a beneficial effect of antidepressants on glucose homeostasis and the opposite. This review aims to structure the conflicting data and focuses on the question, which effect specific antidepressants have on glucose homeostasis. We therefore performed a systematic review of all available studies referenced in Medline from 1960 to 2011. We included antidepressant agents indexed in the Anatomical Therapeutic Chemical (ATC) classification system of the WHO in 2011 and searched for studies investigating their effects on glucose metabolism in clinical samples as well as in healthy subjects. Of 876 studies screened we included 66. Most studies had small sample sizes and lacked a placebo group limiting conclusions about antidepressant effects on glucose tolerance. However, some evidence points to beneficial effects on glucose homeostasis of hydrazine-type monoamine oxidase inhibitors (MAOIs) and selective serotonin reuptake inhibitors (SSRIs). In case of SSRIs, the effect is more pronounced in diabetic patients or patients with comorbid depression and diabetes mellitus. Noradrenegic substances (and possibly also dualacting antidepressants), in contrast, may deteriorate glucose tolerance. They can be used in depressed patients when favorable effects on mood outweigh adverse metabolic effects, but in depressed diabetics this can be at the expense of worsening of glycemic control. The effects of other antidepressants, like bupropione, mirtazapine or newer agents, require further investigation before reliable conclusions can be made. The synthesis of the findings is discussed in light of the specific pharmacodynamic properties of the antidepressants as well as the pathophysiological changes in depression and impaired glucose homeostasis, including animal studies.

Integrity signals

Registry

Crossref · 10.2174/138161212803523662

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cited by

Sorted by citations

Authors
M. Hennings, J., Schaaf, L., & Fulda, S.
Affiliations
Max Planck Society (DE)
Venue
Current Pharmaceutical Design
Published
2012-10-13
Volume
18
Issue
36
Pages
5900-5919
ISSN
1381-6128 (ISSN-L)
OpenAlex
W2099335027
Cited by
64
References
0
Citations by year
2026: 1 · 2025: 5 · 2024: 3 · 2023: 4 · 2022: 8 · 2021: 4 · 2020: 3 · 2019: 8 · 2018: 4 · 2017: 4 · 2016: 5 · 2015: 4 · 2014: 7 · 2013: 4
FWCI
3.52
Type
journal article
Language
en
Open access
closed
Locations
  • Current Pharmaceutical Design (publishedVersion)
  • PubMed (publishedVersion)
  • Max Planck Institute for Plasma Physics (submittedVersion)
  • MPG.PuRe (Max Planck Society) (submittedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
antidepressants, glucose metabolism, glucose homeostasis, impaired glucose tolerance, depression, diabetes mellitus, monoamine oxidase inhibitors, selective serotonin reuptake inhibitors, noradrenergic antidepressants, bupropion, mirtazapine, glycemic control
MeSH terms
Animals, Antidepressive Agents, Blood Glucose, Brain, Depression, Female, Homeostasis, Humans, Insulin Resistance, Male, Risk Factors, Treatment Outcome, Glucose Metabolism Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review